Engineering the Future of Community-Based Trials: How RxE2 is Bringing Clinical Research to the Community Pharmacy

Blog, Community-Based Clinical Trials, Rxe2 Spotlight

Introduction In the highly regulated ecosystem of clinical research, innovation often feels slow, confined by complex protocols and centralized infrastructures. Yet, a quiet revolution is taking place, driven by technology that is fundamentally shifting where and how clinical trials are conducted. At the forefront of this movement is RxE2, and guiding the technological architecture that…

Pharmacists’ Trust Factor: The Key to Unlocking Community-Based Clinical Trials

Blog, Community-Based Clinical Trials

Pharmacists hold a unique and powerful position in healthcare, not only as medication experts but also as some of the most trusted professionals that patients encounter regularly. Trust is an essential element in healthcare because it influences how patients follow treatments, share information, and engage in health programs such as clinical trials. While doctors and…

Hybrid clinical trials

What is a Hybrid Clinical Trial?

Blog, Community-Based Clinical Trials

Introduction: what is a hybrid clinical trial? A hybrid clinical trial is a study design that incorporates elements of traditional in-person clinical trials with decentralized clinical trial (DCT) components. In a hybrid trial, participants may still be required to attend physical clinical sites for certain procedures. However, other study activities can be conducted remotely by…

The Vital Difference: Independent Community Pharmacies vs. Chain Pharmacies

The Vital Difference: Independent Community Pharmacies vs. Chain Pharmacies

Blog, Community-Based Clinical Trials

Introduction In today’s fast-paced world, pharmacies play a vital role in granting people access to fundamental medicines and health services. There are two primary categories of pharmacies: independent community pharmacies and chain pharmacies. Despite serving as crucial healthcare facilities, they differ greatly in treating patients, offering customized services, and incorporating with the community. In this…

“Diversity Now” Protocol – Powered by RxE2

Community-Based Clinical Trials, White Papers

Diversity Now, the first protocol to achieve diversity in clinical trials according to the FDA guidelines for Race and Ethnicity Diversity Plans This plan provides a pharmacist-centered approach for compliance with Section V Categories 4 and 5 of the US Food and Drug Administration’s industry guidance  (hereinafter “FDA Guidance”) for developing the required Race and…

Diversity in Clinical Trials

Diversity in Clinical Trials – How to stop talking about it and actually do it

Blog, Community-Based Clinical Trials

Diversity in Clinical Trials – Background The Federal Drug Administration (FDA) issued non-compulsory guidance on clinical trial diversity to encourage diverse populations in clinical trials and improve the applicability of clinical trial results. The guidance recommends diverse clinical trial populations to better understand the safety and effectiveness of medical products across race, ethnicity, and gender.…

Pharmacists in clinical trials

Moving the Needle: How the Practice of Pharmacy Addresses Key Issues in Clinical Research

Blog, Community-Based Clinical Trials, Gerald Finken

Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. After all, clinical trials are designed to establish the safety and efficacy of drugs: a pharmacist’s specialty. However, pharmacists are rarely consulted in clinical trials. To remedy this issue, Founder and CEO…

E2 Dispensing Webinar

Blog, Clinical Supply Chains, Community-Based Clinical Trials, Webinars

Welcome to our E2 Dispensing Webinar series. Over the next few weeks, we will release 8 episodes, introducing the E2 dispensing methodology and ecosystem to all. These webinars are aimed at everyone involved in clinical research and clinical trials. We will go into RxE2’s innovative and disruptive way of simplifying decentralized clinical trials and more specifically introducing…